Clinical Trial Update: Avelumab in G3 NEC [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on avelumab in neuroendocrine carcinoma across Phase 1 and Phase 2 stages. The study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroendocrine Carcinoma

Drugs mentioned

• Avelumab (avelumab)

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Neuroendocrine Carcinoma | Phase 1, Phase 2 | Status: COMPLETED